ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 89 filers reported holding ARATANA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $622,000 | +60.7% | 120,635 | +12.3% | 0.00% | – |
| Q1 2019 | $387,000 | -41.2% | 107,400 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $658,000 | +4.9% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $627,000 | +37.5% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $456,000 | -3.8% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $474,000 | -16.1% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $565,000 | -14.1% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $658,000 | -15.3% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $777,000 | +36.6% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $569,000 | -26.2% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $771,000 | +110.1% | 107,400 | +356.2% | 0.00% | – |
| Q2 2014 | $367,000 | -31.7% | 23,542 | -37.5% | 0.00% | -100.0% |
| Q1 2014 | $537,000 | – | 37,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |